Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Evommune (EVMN) Enterprise Value (2024 - 2025)

Evommune (EVMN) has disclosed Enterprise Value for 2 consecutive years, with -$149.2 million as the latest value for Q4 2025.

  • On a quarterly basis, Enterprise Value fell 107.11% to -$149.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$149.2 million, a 107.11% decrease, with the full-year FY2025 number at -$149.2 million, down 107.11% from a year prior.
  • Enterprise Value was -$149.2 million for Q4 2025 at Evommune, down from -$76.1 million in the prior quarter.
  • In the past five years, Enterprise Value ranged from a high of -$18.1 million in Q3 2024 to a low of -$149.2 million in Q4 2025.